Tyrvaya

Quote

What milestones will Tyrvaya hit?

  • Tyrvaya will get less than $21.6 million in revenue and less than 131,822 in scripts.

    Votes: 0 0.0%

  • Tyrvaya will get $21.6-24 million in revenue and 131,822-146,469 in scripts.

    Votes: 0 0.0%

  • Tyrvaya will get at least $24 million in revenue and at least 146,469 in scripts.

    Votes: 0 0.0%
  • Total voters
    0
  • Poll closed .

Chris DeMuth Jr

new user
The Viatris deal for Oyster Point Pharma is scheduled to close this week.

The amount (if any) payable under the CVR will be based on the following performance targets to be achieved by Oyster Point for full year 2022:
  • An additional $1.00 per share in cash if Oyster Point Pharma generates equal to or greater than $21.6 million of net product revenues and 131,822 total prescriptions of Tyrvaya; or
  • An additional $2.00 per share in cash if Oyster Point Pharma generates equal to or greater than $24.0 million of net revenue and 146,469 total prescriptions of Tyrvaya
Any sense how Tyrvaya is doing so far this year and if they could hit either of these milestones?
 






Chris DeMuth Jr said:
The Viatris deal for Oyster Point Pharma is scheduled to close this week.

The amount (if any) payable under the CVR will be based on the following performance targets to be achieved by Oyster Point for full year 2022:
  • An additional $1.00 per share in cash if Oyster Point Pharma generates equal to or greater than $21.6 million of net product revenues and 131,822 total prescriptions of Tyrvaya; or
  • An additional $2.00 per share in cash if Oyster Point Pharma generates equal to or greater than $24.0 million of net revenue and 146,469 total prescriptions of Tyrvaya
Any sense how Tyrvaya is doing so far this year and if they could hit either of these milestones?
Click to expand...
 










































anonymous said:
Hey NY! How You Doin'? Next time ask leadership for some Vaseline.
Click to expand...

YOU THINK ITS FUNNY? THE NY TERRITORY MANAGERS ARE NOT GETTING CREDIT FOR THEIR OD’s SCRIPTS AND BEING COMPARED TO THE NATION AND GETTING FINANCIALLY
SCREWED BY THE COMPANY. THE COMPANY IS MAKING OUT BUT NOT THE REP THAT GENERATED THE BUSINESS
 













That’s the leadership you work with. They aren’t paying you probably because they can’t. There are probably legal repercussions since they were promoting a product to a group who are not allowed to prescribe it and they knew it.

this company is total shadiness. People should stay away.
 




























































Top Bottom
Back
Quote